Generic Actoplus Met

Currently, no generic Actoplus Met is available for sale. Although the patent expired in 2011, it is likely that a generic version won't become available until December 2012, due to additional patents that may be allowed to provide protection from generic competition.

Generic Actoplus Met: An Overview

Actoplus Met® (pioglitazone and metformin) is a prescription medication that has been licensed to treat type 2 diabetes. It is a combination of two different diabetes drugs: pioglitazone hydrochloride (Actos®) and metformin hydrochloride (Fortamet®, Glucophage®, Glucophage XR®, Glumetza®, or Riomet®).
 
Actoplus Met is manufactured by Takeda Pharmaceuticals. It is currently under the protection of a patent that prevents any generic Actoplus Met from being manufactured in the United States. Yet, if you search the Internet for "generic Actoplus Met," you may find a number of companies selling it. These medicines may be fake, substandard, and potentially dangerous.
 
There may be generic Actoplus Met available from another country, but there is really no way of knowing if you are getting genuine Actoplus Met or not. You should not buy any generic Actoplus Met until there is an approved generic version available in the United States.
 

When Will Generic Actoplus Met Be Available?

The first listed patent for Actoplus Met expired in January 2011.
 However, there is very good reason to believe that other patents (which expire later) will provide protection against generic competition for this medication. Takeda Pharmaceuticals has settled lawsuits with several generic manufacturers that will allow generic versions of Actoplus Met starting December 14, 2012.
 
Generic Actoplus Met Article Continues on Next Page >
List of references (click here)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
 
Other Articles in This eMedTV Presentation
Referring Pages Articles